KYNB
Price
$5.04
Change
-$0.17 (-3.26%)
Updated
Oct 22 closing price
Capitalization
20.41M
17 days until earnings call
Intraday BUY SELL Signals
SLBT
Price
$1.31
Change
-$0.14 (-9.66%)
Updated
Oct 22 closing price
Capitalization
734.6M
Intraday BUY SELL Signals
Interact to see
Advertisement

KYNB vs SLBT

KYNB vs SLBT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KYNB vs. SLBT commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYNB is a Hold and SLBT is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for KYNB with price predictions
Oct 22, 2026

KYNB in downward trend: 10-day moving average crossed below 50-day moving average on September 25, 2026

The 10-day moving average for KYNB crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

KYNB moved below its 50-day moving average on September 17, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KYNB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for KYNB entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where KYNB advanced for three days, in 234 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

KYNB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.677) is normal, around the industry mean (2.973). P/E Ratio (0.111) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (6.689) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. KYNB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KYNB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for SLBT with price predictions
Oct 22, 2026

SLBT's RSI Oscillator is staying in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for SLBT just turned positive on September 29, 2026. Looking at past instances where SLBT's MACD turned positive, the stock continued to rise in 11 of 22 cases over the following month. The odds of a continued upward trend are 50%.

Following a +2.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where SLBT advanced for three days, in 19 of 31 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

SLBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for SLBT entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. SLBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: SLBT's P/B Ratio (476.190) is very high in comparison to the industry average of (2.973). P/E Ratio (0.000) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (454.545) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
KYNB: Fundamental Ratings
KYNB
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYNBSLBT
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
50%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 9 days ago
61%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
81%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (KYNB: $5.04 vs. SLBT: $1.31)
Brand notoriety: KYNB and SLBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYNB: 34% vs. SLBT: 49%
Market capitalization -- KYNB: $20.41M vs. SLBT: $734.6M
KYNB [@Biotechnology] is valued at $20.41M. SLBT’s [@Biotechnology] market capitalization is $734.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYNB’s FA Score shows that 0 FA rating(s) are green while SLBT’s FA Score has 0 green FA rating(s).

  • KYNB’s FA Score: 0 green, 5 red.
  • SLBT’s FA Score: 0 green, 5 red.
According to our system of comparison, KYNB is a better buy in the long-term than SLBT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYNB’s TA Score shows that 4 TA indicator(s) are bullish while SLBT’s TA Score has 5 bullish TA indicator(s).

  • KYNB’s TA Score: 4 bullish, 4 bearish.
  • SLBT’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SLBT is a better buy in the short-term than KYNB.

Price Growth

KYNB (@Biotechnology) experienced а -5.97% price change this week, while SLBT (@Biotechnology) price change was -15.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.

Reported Earning Dates

KYNB is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
KYNB
Daily Signal:
Gain/Loss:
SLBT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

SLBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLBT has been loosely correlated with NMRA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLBT jumps, then NMRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLBT
1D Price
Change %
SLBT100%
-9.66%
NMRA - SLBT
43%
Loosely correlated
-2.48%
CRVO - SLBT
40%
Loosely correlated
-4.27%
HIND - SLBT
5%
Poorly correlated
-2.17%
KYNB - SLBT
3%
Poorly correlated
-3.26%
MSLE - SLBT
2%
Poorly correlated
-0.90%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPPL2.010.13
+6.91%
Simpple Ltd
SR85.563.05
+3.70%
Spire
GRMN295.404.27
+1.47%
Garmin Ltd
HLXC10.24-0.02
-0.19%
Helix Acquisition Corp III
AMRC19.08-0.76
-3.83%
Ameresco